Skip to main content

Table 4 Months of feline flea and tick coverage acquired by USA cat owners based on annualized ectoparasiticide purchases

From: Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA

Months of coverage

Bravecto® Topical Solution-treated cats

% (n)

Frontline® Gold-treated cats

% (n)

Advantage® II-treated cats

% (n)

1.0–1.9

 

33.6 (3578)

51.2 (1836)

2.0–2.9

67.0 (18,394)a

13.1 (1397)

14.7 (527)

3.0–3.9

0.7 (180)

17.6 (1871)

6.8 (244)

4.0–4.9

0.6 (159)

9.3 (993)

8.2 (292)

5.0–5.9

18.1 (4968)

2.1 (218)

1.8 (66)

6.0–6.9

0.8 (211)

9.8 (1045)

8.4 (302)

7.0–7.9

1.9 (514)

1.5 (157)

1.2 (43)

8.0–8.9

4.7 (1276)

3.8 (409)

2.3 (81)

9.0–9.9

0.7 (179)

2.5 (265)

0.5 (19)

10.0–10.9

2.2 (595)

0.7 (76)

0.5 (18)

11.0–11.9

3.5 (964)

0.6 (58)

0.5 (19)

12.0

 

5.1 (540)

3.8 (136)

  1. aOne dose of Bravecto Topical Solution (fluralaner) provides 12 weeks, or 2.79 months, of coverage